Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis

Published:2015-05-05 Issue:2 Volume:172 Page:287-290
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Rosso Diego A.¹²³,Amaral Diego¹,Latella Antonio⁴,Chantada Guillermo⁵,Braier Jorge L.⁵

Affiliation:

1. Department of Paediatric Haematology & Oncology; Hospital de Niños “Dr Pedro de Elizalde”; Buenos Aires Argentina

2. Department of Paediatrics; Hospital de Clinicas “Jose de San Martin”; Buenos Aires Argentina

3. Department of Pharmacology; School of Medicine; Universidad de Buenos Aires; Buenos Aires Argentina

4. Department of Clinical Paediatrics; Hospital de Pediatría “Dr Juan P. Garrahan”; Buenos Aires Argentina

5. Department of Paediatric Haematology & Oncology; Hospital de Pediatría “Dr Juan P Garrahan”; Buenos Aires Argentina

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13475/fullpdf

Reference10 articles.

1. Treatment of refractory Langerhans cell histiocytosis with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside;Apollonsky;Journal of Pediatric Hematology/Oncology,2009

2. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction;Bernard;European Journal of Cancer,2005

3. Importance of multi-lineage hematologic involvement and hypoalbuminemia at diagnosis in patients with “risk-organ” multi-system Langerhans cell histiocytosis;Braier;Journal of Pediatric Hematology/Oncology,2010

4. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with Langerhans cell histiocytosis with organ dysfunction: experience at a single institution;Egeler;Medical and Pediatric Oncology,1993

5. A randomized trial of treatment for multisystem Langerhans cell histiocytosis;Gadner;The Journal of Pediatrics,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Histiocytoses;Rook's Textbook of Dermatology;2024-03-19

2. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone;BMC Pediatrics;2024-01-03

3. The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with <i>BRAFV600E</i> mutation;Pediatric Hematology/Oncology and Immunopathology;2023-10-17

4. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH;Blood Advances;2023-09-13

5. Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis;Heliyon;2023-09